Colorectal cancer in young adults: what's driving the rise, and what it means for screening

Colorectal cancer incidence has been rising in adults under 50 for roughly three decades while falling steadily in older adults — a genuine reversal of the pattern earlier generations experienced, and one that's accelerating rather than plateauing according to researchers tracking the trend. Among people under 50, colorectal cancer is now the leading cause of cancer-related death, a shift researchers have specifically described as a drastic departure from prior generations' cancer patterns, with the rise concentrated particularly in rectal and sigmoid colon cancers.

The honest research answer for what's driving the increase is that it isn't fully known — obesity, sedentary lifestyle, ultra-processed food consumption, changes in gut microbiome composition, and antibiotic exposure patterns are all under active investigation as contributing factors, but no single explanation accounts for the full magnitude of the trend, and it's affecting people without the traditional risk factors — including normal-weight, physically active individuals with no family history — often enough that risk-factor screening alone won't catch many of these cases.

The clearest response so far has been lowering the recommended screening start age from 50 to 45 for average-risk adults, a guideline change implemented specifically in response to this trend, though screening uptake even at the new lower age threshold remains incomplete, and awareness of colorectal cancer as a real risk for people in their 30s and early 40s — well below any current screening age recommendation — remains limited enough that symptoms in this age group are often initially attributed to less serious causes, contributing to more advanced disease at diagnosis for younger patients.

For anyone under 45 experiencing persistent changes in bowel habits, unexplained rectal bleeding, unexplained abdominal pain, or unintended weight loss, raising colorectal cancer explicitly as a possibility with a physician — rather than assuming it's ruled out by age alone — reflects where the current epidemiological reality actually points, even though formal screening guidelines haven't yet been lowered further to capture this younger population.